If you have type 2 diabetes, your doctor might suggest Soliqua 100/33 as a treatment option for you. Soliqua 100/33 comes as a solution that’s injected under your skin. This article describes the ...
Soliqua 100/33 is a brand-name prescription medication. It’s used with diet and exercise to improve blood sugar levels in adults with type 2 diabetes. Soliqua 100/33 contains two drugs: insulin ...
Sanofi Receives FDA Approval of Soliqua(TM) 100/33, for the Treatment of Adults with Type 2 Diabetes
Paris, France - November 21, 2016 - Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved once-daily Soliqua(TM) 100/33 (insulin glargine & lixisenatide injection) 100 Units ...
Soliqua 100/33 (insulin glargine/lixisenatide) is a prescription drug that’s used to treat type 2 diabetes in adults. The drug’s cost may depend on factors such as your dosage, whether you have health ...
Sanofi announced that the Food and Drug Administration (FDA) has approved Soliqua 100/33 (insulin glargine & lixisenatide injection) for the treatment of adults with type 2 diabetes inadequately ...
The US Food and Drug Administration (FDA) has approved Sanofi's once-daily Soliqua 100/33 (insulin glargine & lixisenatide injection) 100 Units/mL & 33 mcg/mL for the treatment of adults with type 2 ...
Copenhagen, Denmark, September 13, 2017 - Sanofi has announced that in certain adults with type 2 diabetes, Soliqua ® 100/33 (insulin glargine and lixisenatide injection, 100 units/mL and 33 mcg/mL) ...
PARIS, Nov. 21, 2016 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved once-daily Soliqua™ 100/33 (insulin glargine & lixisenatide injection) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results